{ "cik": 1410098, "cik_padded": "0001410098", "entityName": "CorMedix Inc.", "fiscal_years": [ { "accn": "0001213900-26-023889", "filed": "2026-03-05", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2260000.0, "cash": 144837000.0, "cost_of_revenue": 35961000.0, "eps_diluted": 2.04, "free_cash_flow": 172786000.0, "gross_profit": 275748000.0, "net_income": 163055000.0, "operating_cash_flow": 175046000.0, "operating_income": 150141000.0, "revenue": 311709000.0, "stockholders_equity": 405307000.0, "total_assets": 826142000.0, "total_liabilities": 420835000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8846327824990616, "leverage": 1.0383116995265318, "net_margin": 0.5231000708994608, "operating_margin": 0.4816704041269261, "revenue_growth_yoy": 6.1703395288921605, "roa_avg2y": 0.34509432924015965, "roa_period_end": 0.19736921739846178, "roe_avg2y": 0.6655795119641443, "roe_period_end": 0.40229998494968006 } }, { "accn": "0001213900-26-023889", "filed": "2026-03-05", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 116000.0, "cash": 40651000.0, "cost_of_revenue": 3190000.0, "eps_diluted": -0.3, "free_cash_flow": -50731000.0, "gross_profit": 40282000.0, "net_income": -17930000.0, "operating_cash_flow": -50615000.0, "operating_income": -22356000.0, "revenue": 43472000.0, "stockholders_equity": 84657000.0, "total_assets": 118846000.0, "total_liabilities": 34189000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.9266194331983806, "leverage": 0.40385319583732, "net_margin": -0.41244939271255066, "operating_margin": -0.514262053735738, "roa_avg2y": -0.17849147200747262, "roa_period_end": -0.15086750921360417, "roe_avg2y": -0.2316552432509254, "roe_period_end": -0.2117958349575345 } }, { "accn": "0001213900-26-023889", "filed": "2026-03-05", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 327300.0, "cash": 43642684.0, "eps_diluted": -0.91, "free_cash_flow": -38736780.0, "net_income": -46339227.0, "operating_cash_flow": -38409480.0, "operating_income": -48957788.0, "stockholders_equity": 70142000.0, "total_assets": 82059957.0, "total_liabilities": 11917528.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1699057340822902, "roa_avg2y": -0.6431617029873569, "roa_period_end": -0.5646996256651706, "roe_avg2y": -0.7402329788781843, "roe_period_end": -0.6606487838955262 } }, { "accn": "0001213900-24-021585", "filed": "2025-03-25", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 219360.0, "cash": 43148323.0, "cost_of_revenue": 3734.0, "eps_diluted": -0.74, "free_cash_flow": -24576092.0, "gross_profit": 61674.0, "net_income": -29701705.0, "operating_cash_flow": -24356732.0, "operating_income": -30623968.0, "revenue": 65408.0, "stockholders_equity": 55059736.0, "total_assets": 62038259.0, "total_liabilities": 6978523.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.9429121819960861, "leverage": 0.12674457792532823, "revenue_growth_yoy": -0.6574349520258097, "roa_avg2y": -0.4535171076644687, "roa_period_end": -0.4787643218678977, "roe_avg2y": -0.5040261101761756, "roe_period_end": -0.5394451037687503 } }, { "accn": "0001213900-24-021585", "filed": "2024-03-12", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1425329.0, "cash": 53317405.0, "cost_of_revenue": 148938.0, "eps_diluted": -0.75, "free_cash_flow": -22580552.0, "gross_profit": 41998.0, "net_income": -28210226.0, "operating_cash_flow": -21155223.0, "operating_income": -29437585.0, "revenue": 190936.0, "stockholders_equity": 62798067.0, "total_assets": 68945576.0, "total_liabilities": 6147509.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.2199585201324004, "leverage": 0.09789328388085576, "revenue_growth_yoy": -0.20187601105207936, "roa_avg2y": -0.4771129072222654, "roa_period_end": -0.40916658670021117, "roe_avg2y": -0.5271900874780004, "roe_period_end": -0.44922124752661574 } }, { "accn": "0001213900-23-024310", "filed": "2023-03-30", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 112638.0, "cash": 41905469.0, "cost_of_revenue": 204846.0, "free_cash_flow": -22080276.0, "gross_profit": 34385.0, "net_income": -22027683.0, "operating_cash_flow": -21967638.0, "operating_income": -27220752.0, "revenue": 239231.0, "stockholders_equity": 44223012.0, "total_assets": 49308303.0, "total_liabilities": 5085291.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.143731372606393, "leverage": 0.11499196391236309, "revenue_growth_yoy": -0.15545459038500914, "roa_avg2y": -0.5591902783873719, "roa_period_end": -0.44673374786392467, "roe_avg2y": -0.6491209453373833, "roe_period_end": -0.4981045388767278 } }, { "accn": "0001213900-22-015852", "filed": "2022-03-29", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 36571.0, "cash": 16350237.0, "cost_of_revenue": 373234.0, "free_cash_flow": -15088595.0, "gross_profit": -89968.0, "net_income": -16433074.0, "operating_cash_flow": -15052024.0, "operating_income": -21007876.0, "revenue": 283266.0, "stockholders_equity": 23646260.0, "total_assets": 29475910.0, "total_liabilities": 5829650.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": -0.3176095966335529, "leverage": 0.24653581581188738, "revenue_growth_yoy": -0.34093071845545686, "roa_avg2y": -0.6804328548752113, "roa_period_end": -0.5575086231434415, "roe_avg2y": -1.1499494673206554, "roe_period_end": -0.694954466372272 } }, { "accn": "0001213900-21-018684", "filed": "2021-03-30", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 48893.0, "cash": 17623770.0, "cost_of_revenue": 396786.0, "free_cash_flow": -23749458.0, "gross_profit": 33011.0, "net_income": -26829630.0, "operating_cash_flow": -23700565.0, "operating_income": -26864196.0, "revenue": 429797.0, "stockholders_equity": 4934255.0, "total_assets": 18825914.0, "total_liabilities": 13891658.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.07680602703136596, "leverage": 2.815350645639514, "revenue_growth_yoy": 0.30507671706237266, "roa_avg2y": -1.6623145704501017, "roa_period_end": -1.4251435547830509, "roe_avg2y": -4.424555019350068 } }, { "accn": "0001654954-19-006678", "filed": "2020-03-16", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 151988.0, "cash": 10379729.0, "cost_of_revenue": 114964.0, "free_cash_flow": -28739168.0, "gross_profit": 214363.0, "net_income": -33009914.0, "operating_cash_flow": -28587180.0, "operating_income": -32924110.0, "revenue": 329327.0, "stockholders_equity": 7193351.0, "total_assets": 13453933.0, "total_liabilities": 6260582.0 }, "period_end": "2017-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6509123151153716, "leverage": 0.8703290024357215, "revenue_growth_yoy": 0.469520983467571, "roa_avg2y": -1.8670597400436348, "roe_avg2y": -2.639961320986983, "roe_period_end": -4.5889480438254715 } }, { "accn": "0001654954-19-006678", "filed": "2019-05-29", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 58723.0, "cash": 8064490.0, "cost_of_revenue": 366673.0, "free_cash_flow": -22324118.0, "gross_profit": -142568.0, "net_income": -24643627.0, "operating_cash_flow": -22265395.0, "operating_income": -24760918.0, "revenue": 224105.0, "stockholders_equity": 17814526.0, "total_assets": 21906386.0, "total_liabilities": 4091860.0 }, "period_end": "2016-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": -0.6361660828629437, "leverage": 0.22969233085404575, "revenue_growth_yoy": 0.06650644838909246, "roa_period_end": -1.1249517378174565, "roe_period_end": -1.3833445245750575 } }, { "accn": "0001654954-17-002094", "filed": "2017-03-16", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "cost_of_revenue": "USD", "gross_profit": "USD", "revenue": "USD" }, "fundamentals": { "cost_of_revenue": 318718.0, "gross_profit": -108588.0, "revenue": 210130.0 }, "period_end": "2015-12-31", "ratio_units": { "gross_margin": "ratio" }, "ratios": { "gross_margin": -0.5167658116404131 } } ], "latest_filing": { "accn": "0001213900-26-023889", "filed": "2026-03-05", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001410098.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001410098.json" }, "ticker": "CRMD" }